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Abstract The class A Ca 2+ channel ¢xl snbunit (cdA) was 
expressed in Xenopus oocytes alone or in combination with the 
I~lb, l~2a, 113, or I]4 subunit. Analysis of voltage-dependent 
activation and inactivation in the presence of 1.8 mM external 
Ca 2+ showed an hyperpolarising shift of both relations when 
compared to similar recordings performed in the presence of 40 
mM Ba 2+. These shifts, which differed for activation and 
inactivation, were strongly modulated by the nature of the co- 
expressed ~ subunit. On the other hand, for each combination, 
the kinetics of inactivation were similar in 1.8 mM Ca 2+ and 40 
mM Ba z+ (for example co-expression of the l~2a subuult reduced 
inactivation using either 40 mM Ba 2+ or 1.8 mM Ca2+). Thus, 
modulation of channel properties by the ~ subunit is different in 
physiological Ca 2+ or high Ba 2÷ concentrations. These results 
must be taken into consideration to extrapolate the role of the 
subunit in native cells. 
Key words: P- and Q-type Ca 2+ channels; cdA subunit; 
coConotoxin MVII C; Rat brain 
1. Introduction 
Taking advantage of the isolation of a new spider-toxin 
from Agelenopsis aperta (¢0Aga-IV A), two new types of neu- 
ronal Ca 2+ currents have been recently identified. The P-type 
Ca 2+ current displays a high-activation threshold (> -40  
mV), almost no inactivation, nanomolar sensitivity to o~Aga- 
IV A, and micromolar sensitivity to the cone snail peptide 
~0CmTx-MVII C. The Q-type Ca z+ current, exhibiting the 
same voltage range for activation, is poorly inhibited by 
~0Aga-IV A but is more sensitive to ¢oCmTx-MVII C ([1-5], 
for review [6]). The physiological roles of these P- and Q-type 
Ca 2+ channels are not yet fully understood, but it has been 
suggested that both types play a crucial role in the Ca2+-de - 
pendent neurotransmitter release in central synapses and at 
the mammalian euromuscular junction [7-9]. 
Neuronal Ca 2+ channels are composed of a central pore- 
forming c~l subunit associated with at least 2 different auxili- 
ary subunits ¢x2-8 and I~ [10-12]. The ctl subunit specifies the 
gating kinetics and the pharmacological profile of the channel 
[4,13]. Each of the [3 subunits (four genes identified to date) 
modulates pecifically the kinetics and the voltage-dependent 
gating of the al subunit [3,14-16]. The ct2-8 subunit (only one 
gene identified so far, [11]) seems to have only minor regula- 
tory role on cd current properties. 
The molecular components of the P- and Q-type Ca z+ 
channels have not been completely identified. However, in 
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situ hybridisation and immuno-localisation experiments have 
shown that the class A ctl subunit is expressed in Purkinje 
cells [17,18] and at the neuromuscular junction [19], where P- 
type Ca 2+ currents are known to be predominant [2,6]. This 
ctlA subunit, when expressed in Xenopus oocytes, encodes a 
¢oCmTx-MVII C-sensitive Ca 2+ channel, closely related to the 
Q-type Ca ~+ channel described in neurones [3]. Therefore, it 
has been suggested that both channels might be encoded by 
the same c~l subunit class A gene: the functional differences 
being related to either alternative splicing and/or the nature of 
auxiliary subunits [4,9,10]. The identification of the molecular 
components of the functional P- and Q-type Ca 2+ channels 
might thus be assessed by comparing the biophysical and 
pharmacological properties of P- and Q-type Ca 2+ channels 
recorded in vivo with the a lA  channel currents expressed with 
different combinations of auxiliary subunits, using similar ex- 
perimental conditions. 
However, the biophysical characterisation f ~lA-directed 
current and the modulation by auxiliary I~ subunits have only 
been performed, in previous tudies, by using Ba 2+ ions as the 
charge carrier [3,4,16,18]. Such a modulation may not be sim- 
ply extrapolated to the physiological situation since the nature 
and the concentration of the permeating ion are known to 
regulate voltage-dependent properties of Ca 2+ channels 
when recorded in native cells. As a first step towards the 
understanding of the potential regulatory role in vivo of the 
13 subunit, we have analysed Ca 2+ channel currents in Xenopus 
oocytes injected with various combinations of a lA  and 13 
subunits, in normal saline solution containing 1.8 mM Ca 2+. 
2. Materials and methods 
2.1. Plasmid amplification and preparation 
The ~IA, cc2-8, 151b [20], 132a [21], [33 [22] and 154 [23] subunit 
cDNAs were inserted into the pmt2 expression vector under the con- 
trol of a SV40 promoter [15]. Large-scale plasmid preparations were 
obtained using standard protocols (Qiagen Inc., Chadworth, CA). 
Each sample was dissolved in sterile water at a final concentration 
of 1 ng/nl. Mixtures of cDNAs (ctl, ctl+13) were made by mixing the 
o~1 cDNA with an equal volume of the appropriate subunit or sterile 
water. Final ~1 cDNA concentration was 0.5 ng/nl. 
2.2. Xenopus oocytes i olation and injection 
Ovaries were surgically removed from Xenopus laevis female (Ele- 
vage de Lavalette, Montpellier, France) anaesthetised using a 0.2% 
MS222 solution (Sigma, Laverpilliere, France). After a first mechan- 
ical dissociation and extensive washing using the OR-2 solution, (con- 
raining in mM: NaC1, 100; MgC12, 2; KCI, 2; HEPES, 10), oocytes 
were isolated by a 2 h enzymatic dissociation using 1 mg/ml collage- 
nase IA (Sigma) dissolved in OR-2. Oocytes were then washed several 
times with OR-2 and selected in the survival medium (containing in 
mM: NaC1, 96; MgC12, 2; KC1, 2; CaC12, 1.8; HEPES, 10; pyruvic 
acid, 2.5; gentamycin, 50 ~tg/ml; neutralised at pH 7.2 using NaOH). 
Nuclear injection of oocytes was performed by employing a home- 
made pneumatic njector. Oocytes were then incubated for 2-7 days at 
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19°C under gentle agitation before recording. The survival medium 
was renewed aily. 
2.3. Electrophysiological recordings 
Whole cell Ca 2+ currents were recorded under two electrode vol- 
tage-clamp by employing the GeneClamp 500 amplifier (Axon Inst., 
Burlingame, CA). Current and voltage electrodes were filled with a 
solution containing: CsC1, 2.8 M; BAPTA, 10 raM; pH = 7.2 with 
CsOH. The bath-clamp headstage was connected to the bath using 
two agar bridges filled with 2% agar in 3 M KC1. Injection of BAPTA 
(in mM: BAPTA-free acid (Sigma), 100; CsOH, 10; HEPES, 10; pH 
7.2) was performed using a third microelectrode. Under these condi- 
tions uncontaminated Ca 2+ currents can be recorded, Ca 2+ currents 
were elicited by series of depolarising steps of 400 ms duration from a 
holding potential of -100 to -40 mV, and up to +60 mV in 10 mV 
increment. Voltage-dependent i activation was assessed by applying 
preconditioning voltage steps of 2.5 s duration to various test poten- 
tials. The standard extracellular recording solutions had the following 
composition (in raM) ND96: NaCI, 96; MgC12, 2; KC1, 2; CaC12, 
1.8; HEPES, 10; pH 7.2 (using NaOH) and BA40: BaOH, 40; 
TEAOH, 20; NMDG, 30; CsOH, 2; HEPES, 10; pH 7.2 (using 
methane sulfonate). Current recordings were filtered and digitised 
using a DMA-Tecmar labmaster, and subsequently stored on an 
IPC 486 personal computer by using the version 6.02 of the pClamp 
software (Axon Inst.). Peak current, time-to-peak and inactivation 
time-constants were measured using Clampfit (pClamp ver. 6.02, 
Axon Inst,). Normalised current-to-voltage relations were fitted ac- 
cording to a modified Boltzmann distribution using the equation: 
i/imax = g*( V--erev)/(l + exp((V-E1/2a)/ka)), 
where g is a normalised conductance, V is the voltage step, Erev is the 
current reversal potential, El/2a is the potential for half-activation, ka 
is the slope factor and im~x is the current at the peak of the current-to- 
voltage curve. Inactivation curves were fitted using the equation: 
i / Imax = R 4- ( l - -R ) / (1  4 -exp( (V -E1 /2 i ) /k i ) )  , 
where V is the preconditioning voltage, R is the fraction of non-in- 
activating current, E1/2i is the potential of half-inactivation, ki is a 
slope factor and/max is the current recorded after a predepolarising 
pulse at -80 inV. All values are presented as mean+standard 
deviation. ~oCmTx-MVII C (RBI, Bioblock Scientific, lllkirch France) 
was dissolved in distilled water to make a stock solution at 0.1 mM 
and subsequently stored at -80°C. The final dilution in ND96 (1 ~M) 
was made just before the experiment. The toxin was added at the 
desired concentration to the bath and the effect was measured as 
the percentage of inhibition of the Ca 2+ current recorded uring a 
depolarising pulse from -100 to +10 mV, when the steady-state effect 
was reached (after = 2-5 min). 
3. Results 
The intracellular injection of BAPTA in Xenopus oocytes 
[24] and the use of the highly efficient pmt2 expression vector, 
enable recordings of the txlA Ca 2+ channel activity at a low 
Ca 2+ concentration (1.8 mM). In these conditions, the con- 
tamination by the endogenous Ca 2+ channel [25] is negligible, 
as shown for low concentrations of Ba 2+ [26]. 
Fig. 1 shows currents recorded from oocytes expressing 
different combinations of Ca 2÷ channel subunits: the otlA 
subunit alone or co-expressed with either the ~llb, 132a, 133, 
or 134 subunit. Voltage pulses of 400 ms duration were applied 
from a holding potential of -100  mV to -40 ,  -20,  0, 20 and 
40 mV every 15 s. The level of expression, as estimated by the 
amplitude of the Ca 2+ current, was very variable, but currents 
in the range of -200  to -1000 nA were routinely recorded 
from all combinations in the presence of 1.8 mM extracellular 
Ca 2+. As expected, the mean current amplitude was signifi- 
cantly increased upon co-expression of a 13 subunit (from 
-235+75 nA for (xlA alone, to up to -1220+547 nA for 
ctlA+132a). Currents recorded from oocytes expressing the 
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Fig. 1. Typical current races recorded from oocytes expressing the 
¢tlA, the ctlA+~lb, the ctlA+132a, the etlA+153 or the ctlA+l~4 sub- 
units. Currents were evoked by 400 ms long step depolarisations to
-40, -20, 0, 20 or 40 mV from a holding potential of -100 mV. 
The recording solution contained 1.8 mM extracellular Ca 2+. 
(zlA subunit alone peaked and slowly decayed during the de- 
polarising pulse. In contrast, co-expression of the 131b, [53, or 
134 subunit induced a significant acceleration i  the activation 
and inactivation kinetics. Co-expression of the 152a subunit 
had opposite effects, and Ca 2÷ currents recorded from oocytes 
expressing the alA+132a subunits had typical slow onset of 
activation and inactivation decay (see below). 
This ct lA Ca 2+ current was high-voltage activated, and no 
inward current was observed with depolarising pulses below 
-30  mV. As seen in Fig. 2A, the threshold for activation was 
not changed by the co-expression of a 13 subunit in 1.8 mM 
Ca 2+. However, co-expression of the 131b, 133 or 134 subunit 
induced a leftward shift in the peak of the current-to-voltage 
curve (peak at +10 mV for otlA alone and 0 mV for 
ctlA+131b, txlA+133 or alA+~4), and currents through the 
ctlA+132a subunits peaked at even more hyperpolarised po- 
tential ( -10  mV, see Table 1 for half-activation potentials). 
When comparing to similar recordings performed in 40 mM 
Ba 2+, the potential for half-activation was shifted in the neg- 
ative direction for all subunit combinations. The magnitude of 
this shift, however, was more pronounced for currents re- 
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Fig. 2. A: Effect induced by the co-expression of a 13 subunit on the current-voltage relationship recorded at 1.8 mM Ca 2+. Currents were re- 
corded from oocytes injected with the ctlA, the cdA+l~lb, the ctlA+132a, the ctlA+133 or the c~IA+IM subunit cDNAs at different depolarising 
potentials (from -40 to +50 mV, 10 mV increment from a holding potential of -100 mV). The peak current was then normalised with respect 
to the maximum current and plotted against the depolarising potential. Note the differential shift in the current-to-voltage relationship induced 
by co-expression of the 13 subunit. B: Comparison of the potential for half-activation i  1.8 mM Ca 2+ and 40 mM Ba 2+. Currents were re- 
corded as described in A in ND96 or Ba40. 
corded from oocytes expressing the c~lA+132a subunits, which 
becomes the combination with the lowest activation range (see 
Fig. 2B). On the other hand, the modification of the slope of 
the activation-curve induced by the co-expression of a 13 sub- 
unit in 40 mM Ba 2+ [16] was also observed in 1.8 mM Ca 2+ (a 
change in the slope from ka = 7 mV/e-fold with the ctlA sub- 
unit to/ca = 4 to 5 mV/e-fold when 13 is present, see Table 1). 
By contrast o previous reports using Ba 2+ as the charge 
carrier, in 1.8 mM Ca 2+, a 13 subunit-induced hyperpolarising 
shift of the ctlA Ca 2+ currents inactivation-curve was re- 
corded only when expressed with the 131b, 133, or 134 subunit 
(24, 22 and 21 mV, respectively, see Fig. 3A and Table 2). In 
these conditions, co-expression of the 132a subunit had no 
effect on the voltage-dependence of inactivation (see Fig. 
3A). Therefore, and as noted for activation, the rank of order 
of the 13 subunit with respect o the potential for half-inacti- 
vation was not the same in high Ba 2+ (134= 133 < 131b= 132a, 
Fig. 3B and [16]) or in 1.8 mM Ca 2+ (131b = 133 = 134 < 132a, 
Fig. 3B, Table 2). This 'late' voltage-dependent i activation 
Table 1 
Current-to-voltage curve parameters 
Combination E1/2a(mV) k~(mV) 
ctl (7) - 4.5+4.3 -7.3+1.7 
ctl+131b (20) -13.2+3.1 -4.5_+0.5 
ctl+132a (16) -17.9+3.4 -4.1-+0.5 
<x1+133 (6) -11.2-+4.8 -5.6-+0.8 
cd+134 (9) - 12.0 -+ 2.5 -4.9 _+ 0.6 
See Section 2 for detail; numbers between parenthesis ndicate the 
number of oocytes tested. 
of the ctlA channel containing the 132a subunit, together with 
the reduction in the extent of inactivation (see Fig. 3A) should 
allow persistant Ca 2+ entry at depolarised potentials. While 
injection of ctlA, ctlA+131b, ctlA+133 and ctlA+134 subunits 
produced Ca 2+ channels that completely inactivated (> 90%) 
when the holding potential was depolarised (> -10  mV), a 
2.5 s long pulse at +20 mV failed to inactivate the Ca 2+ 
current by more than 50% on oocytes expressing alA+132a 
subunits (see Table 2 and Fig. 3A). Therefore, at low Ca 2+ 
concentrations, while the 132a subunit was the most potent 13 
subunit in shifting the activation curve of the class A ctl 
subunit, it was the less efficient in displacing the inactivation 
curve, although it produced important changes in the extent 
and the kinetics of inactivation. 
As shown in Fig. 4A, the inactivation decay of the class A 
does not seem to be strongly voltage-dependent (308 + 75 ms 
at -10  mV and 241 +55 ms at +10 mV for the etlA subunit 
expressed alone). Although this poor voltage-dependency was 
also found upon co-expression of the 131b, 133 and 134 subunits, 
we noted important modifications in the time constant of in- 
activation. An acceleration was observed when the 131b, 133 
and 134 subunits were co-expressed, while co-expression of 
the 132a subunit induced a marked slowing of the current 
decay (see Fig. 4A), which appeared to depend on the ampli- 
tude of the voltage step (see Figs. 1 and 4A). Similarly, the 
time-to-peak for activation was also slightly voltage-depen- 
dent and was decreased by co-expression of the 131b, [33, 
and 134 subunits or increased by the 132a subunit (Fig. 4B). 
We finally studied the influence of the 13 subunit on the 
inhibition of the ctlA Ca 2+ current by the cone snail toxin 
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Fig. 3. A: Steady-state inactivation curves recorded from oocytes injected with the ~IA, the odA+[$1b, the alA+[~2a, the 0clA+[~3 or the 
colA+J34 subunit cDNAs. B: Comparison of the potential for half-inactivation in 1.8 mM Ca 2+ and 40 mM Ba 2+. Currents were recorded as 
described in A in ND96 or Ba40. 
0~CmTx-MVII C. When 1 pM of this toxin was applied (in 1.8 
mM extracellular Ca 2+) on oocytes expressing the a lA  sub- 
unit alone, an almost complete and reversible inhibition of the 
current was recorded. This inhibition was not significantly 
different (P<0.05) when either the 131b (77+10%, n=4), 
the 132a (80+ 10, n=2), the 133 (79+ 10%, n=7) or the ~4 
(85 + 5%, n = 2) subunit was co-expressed with the cdA sub- 
unit. 
The cx2-8 subunit has also been shown to be present in the 
czlA, ¢zlB and ¢zlC Ca 2+ channel complexes, and suggested to 
modulate Ca 2+ channel activity. We therefore checked for the 
possible influence of the c~2-8 subunit in the presence of 1.8 
mM Ca 2+ by comparing the electrophysiological properties of 
Ca 2+ channels expressed in oocytes injected with either the 
cdA+131b subunits or the czlA+131b+cc2-15 subunits. As seen 
in Table 3, the 0~2-8 subunit had no influence on the kinetics 
and voltage-dependency of activation and inactivation of the 
expressed currents. Moreover, no effect was observed on the 
sensitivity to the toxin coCmTx-MVII C (Table 3). The expres- 
sion of the cz2-15 subunit induced however, when expressed 
with the czlA and 131b subunits, the usual increase in the 
expressed Ca 2+ current, as already noted for the class C, B 
and A Ca 2+ channels using 40 mM Ba 2+ as the charge carrier 
(not shown, but see [3,14-16,18]). 
4. Discussion 
These results constitute the first characterisation f the class 
A Ca 2+ channel recorded at physiological concentration of
Ca 2+. Up to now, most of the studies concerning the class 
A channel has been conducted in Xenopus oocytes, using high 
divalent cation concentrations (40 mM or 10 Ba 2+ [3,16,18]). 
Recently, two groups reported the characterisation f the class 
A Ca 2+ channel at 10 and 1 mM Ca 2+ concentrations after 
stable expression i  Hamster Kidney cells or mdg cells [27,28], 
but the well-known modulation of the czlA channel properties 
by the auxiliary ~ subunit has never been studied in such 
conditions. 
The comparison of the 13 subunit-induced changes in the 
cdA-subunit properties using either 1.8 mM extracellular 
Ca 2+ (this study) or 40 mM Ba 2+ [3,16,18] evidences simila- 
rities but also marked differences, that may be physiologically 
important. We show here that the modulation of the activa- 
tion and inactivation kinetics upon co-expression of the 131b, 
133, [M or even the ~2a subunits, are similar either in 1.8 mM 
Ca 2+ (this work), 2 mM Ba 2+ [3] or 40 mM Ba 2+ concentra- 
tions [16,18], suggesting that this modulation of the class A 
Ca 2+ channel kinetics is affected neither by the nature of the 
permeating ions nor by its concentration. Similar conclusions 
can be drawn on the role of the cz2-8 subunit (this work in 1.8 
mM Ca 2+, and [16-18]). The regulation of the voltage-depen- 
dent gating by [~ subunits is, however, clearly influenced by 
the permeating ion. 
Table 2 
Inactivation curve parameters 
Combination E1/21(mV) ki(mV) R 
c~l (5) -- 19.6 + 2.2 --8.0 + 0.8 0.08 + 0.08 
cd +lib (16) -43.8 + 3.9 -7.2 + 1 0.05 + 0.09 
cd +l]2a (3) -19.2_+6.2 --4.7_+0.4 0.53_+0.04 
cd+l]3 (6) -41.8+_4.8 -7-+1.0 0.11-+0.13 
czl+~4 (3) -40.6 _+ 3.9 -7.9 + 0.9 0.02 + 0.02 
See Section 2 for detail; numbers between parenthesis indicate the 
number of oocytes tested. 
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Fig. 4. Inactivation time constant (A) and current ime-to-peak (B) recorded from oocytes injected with the indicated combination of subunits 
at 3 different voltages (-10, 0 and 10 mV). 
Using 40 mM extracellular Ba 2+, the different 13 subunits 
have been classified according to their ability to shift the acti- 
vation curve [16,18]. In these conditions, expression of the 134 
subunit produced cdA Ca 2+ channels with the lowest activa- 
tion range (see Fig. 2B and [16,18]). At a physiological Ca 2+ 
concentration, this subunit induced one of the smallest hyper- 
polarising shift of the current-to-voltage curve, and the 132a 
subunit-containing channel became the channel with the low- 
est activation potential (see Fig. 2B). Similar differences have 
been noted in the voltage-dependence of the inactivation. In a 
first study, using a 40 mM BaC12-containing Na-free solution, 
Stea and coworkers [18] reported that co-expression of a 13 
subunit induced either a leftward (with the 131b, the 133 or 
the 134 subunit) or a rightward (with the 132a subunit) shift 
of the inactivation curve of the a lA  Ca 2+ channel. In another 
recent study ([16], using 40 rnM Ba2+-methane sulfonate), all 
four 13 subunits were found to induce an hyperpolarising shift 
of the inactivation curve when compare to ~IA expressed 
alone. Our work, in 1.8 mM Ca 2+, shows that, while the 
131b, 133 and 134 subunits induced a 20-25 mV hyperpolarising 
shift in the inactivation curve, the fl2a subunit had no effect 
on the voltage dependence of inactivation (Fig. 2A). We be- 
lieve that the discrepancy between these values (obtained un- 
der different ionic conditions) can be explained by modifica- 
tions in the sensitivity of ctlA Ca 2+ channel inactivation to 
Table 3 
Functional effects of the expression of the c~2-~5 subunit 
the external surface potential. These results would therefore 
suggest that (1) the activation and inactivation parameters are 
differentially affected by the external surface potential and (2) 
co-expression of the 131b, 132a, I]3 or 134 subunit can modify 
the sensitivity of the activation and inactivation processes to 
external surface potential. 
From a physiological point of view, one important conse- 
quence is the fact that at an holding potential of -40  mV, 
more than 50% of the channels containing the 131b, 133 or 134 
will be inactivated. At this potential, however, 100% of the 
132a-containing channels are still available for opening. These 
differences, together with the changes in the kinetics of inac- 
tivation, suggest hat the 132a-containing channels are more 
resistant to high bursting activity where cumulative inactiva- 
tion can occur. 
All combinations of subunits tested in the presence of 1.8 
mM extracellular Ca 2+ showed a high sensitivity to the snail- 
toxin o~CmTx-MVII C, since a block of about 80% was re- 
corded in 2-5 min upon perfusion of 1 ~tM of the toxin. This 
block is characteristic of the cxlA Ca 2+ channel, irrespective 
to the 13 subunit expressed, and might therefore help, together 
with the insensitivity to dihydropyridine and 03CgTx-GVI A, 
to the identification of functional ~xlA Ca 2+ channels ex- 
pressed in vivo (P- or Q-type Ca 2+ channels, [4,5,18]). The 
use of Xenopus oocytes to record Ca 2+ channels activity under 
Combination Activation Inactivation Tau inac. at Time-to-peak % Block 
0 mV at 0 mV o~MVIIC 
E1/2~ k, Ell~i ki 
(mV) (mV) (mV) (mV) (ms) (ms) 
al+[31b -13.2+3.1 (20)  -4.5+0.5 (20) -43.8+3.9 (16) 7.2+1 (16) 174+31 (17)  14.7+3.2 (20) 77+10 (4) 
~xl+~2-8+l~lb -10.9+3.1 (6) -4.6+0.3 (6) -40.4+5.8 (7) 7.3+0.5 (7) 175+28 (6) 17.2+4.4 (6) 88 + 11 (4) 
Values for the ~xlA+l]lb combination are taken from Tables 1 and 2. Numbers between parenthesis ndicate the number of oocytes tested. 
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conditions similar to those employed for isolated cells (or 
tissue slices) may help in the future to identify the subunit 
composition of native channels. 
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